GEIVEX Treasurer has been awarded with the XII national prize for cancer research Diz Pintado. https://www.lagacetadesalamanca.es/salamanca/hector-peinado-recibe-el-premio-diz-pintado-y-reclama-mas-financiacion-para-luchar-contra-las-metastasis-JH13140382?s=08 https://www.salamanca24horas.com/local/hector-peinado-investigador-cancer-combinacion-de-terapias-dirigidas-con-inmunoterapia-es-futuro_15067587_102.html Congrats to our treasurer!
Read MoreGEIVEX Member Dr Pilar Martín Duque has been awarded with the annual prize of the Medicine Academy of Zaragoza 2022. In the opening of the new course she will also be named member of this Academy. More information at http://www.ramz.es/WebRAMZ/seccion8.do?enlaceMenu=seccion8.
Read MoreYa están abiertas las inscripciones para el Curso Avanzado GEIVEX-UFV en Vesículas Extracelulares (en español). NUEVA Fecha límite inscripción: 3 de marzo 2023 El curso tiene una duración de 40h de Mayo a Junio de 2023 Miembros de GEIVEX y alumnos de la Universidad Francisco de Vitoria 50€ | Miembros de CNIO, de países en […]
Read MoreCongrats! We are sure that Fernando will impulse the quality of this new journal that already counts with renowned researchers in its Editorial Board such as Richard Simpson, Benedetta Bussolati
Read MoreGEIVEX members Dr Fernando de la Cuesta and Dr Gloria Alvarez-Llamas are Guest Editors of an Special Issue with the Topic: Beyond Liquid Biopsy: Extracellular Vesicles for Biomarker Discovery of Human Diseases in the Journal Extracellular Vesicles and Circulating Nucleic Acids ISSN 2767-6641 (Online) Submission deadline: 31 May 2023 https://evcna.com/journal/special_detail/1322?fbclid=IwAR1cfHWraDRnJOmqW69ZqR5R0Qqhg7VEO5TAanozY1ZLH6T9L81NJ9FfRU4
Read MoreIn this study, the group of Pilar Martín-Duque showed that a nanoscale vector based on ultrasmall PtNPs and exosomes exhibits antitumoral properties comparable or higher to those of the FDA approved cisplatin. They demonstrated their anticancer properties both in vitro and in vivo comparing the results obtained with the administration of equivalent amounts of cisplatin, […]
Read More